Title
Category
Credits
Event date
Cost
$0.00
During this 1-hour event, Dr. David Holtzman moderated a panel of experts including, Gil Rabinovici, MD, UCSF, Suzanne Schindler, MD, PhD, Washington University, and Theresa Gomez-Isla, MD, MGH, Massachusetts General Hospital to explore what we know about Aduhelm. 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
This is the kickoff event for, "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment," a series of presentations with interactive discussions brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).Moderator: Karen Johnston, MD (Professor Neurology, UVA)
$0.00
On Tuesday, June 20 the ANA convened academic neurologists from the LGBTQ+ community for a virtual roundtable discussion on improving the professional and educational climate within academic medicine and their experiences as LGBTQ+ physician-scientists. 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Hosted by Lindsey Wooliscroft (OHSU Health Care) and Amanda Jagolino-Cole (UT Health), and featuring panelists: Matthew Robbins (Weill Cornell Medicine), Kelly Mills (Johns Hopkins University), Kathryn Davis (University of Pennsylvania), and Diogo Haussen (Emory University School of Medicine), this 60-minute discussion between neurologists in academia about the neurologic procedures they perform, focusing on both the science supporting these procedures and a career development perspective on incorporating these procedures into their practice. 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
This is the second event for "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment," a series of presentations with interactive discussions brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).Speaker: Louise D. McCullough, MD, PhD
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
This is the fourth event in the series, "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment." This series of presentations with interactive discussions brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
This is the fifth event for, "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment.” This series of presentations with interactive discussions is brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
This is the eighth event in the series, "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment." This series of presentations with interactive discussions brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).
  • 2.25 AMA PRA Category 1 Credit™
  • 2.25 Participation
$99.00
Next-level foundational principles in statistics for the Neurological Researcher.
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$49.00
What does the word Placebo mean to you? Randomized, placebo controlled clinical trials have been the mainstay of clinical science for decades. Physicians, and medical researchers may assume that they understand the underlying concepts of a placebo controlled trial, but automatically assuming that rigorous research equates to placebo controlled trials is inaccurate. In this ANA Highlights, we will talk about placebos, what we can learn from them, as well as situations where alternative study designs should be considered. Watch this 20-minute video to learn more.

Pages